Panacea Biotec Ltd.

BSE: 531349 | NSE: PANACEABIO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE922B01023 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Panacea Biotec Panacea Biotec Ltd. | BSE 320.00 -7.70 (-2.35%) | NSE 319.65 -6.75 (-2.07%) | Trade | Add

BSE Live

Mar 04, 10:52

320.00 -7.70 (-2.35%)

Volume

AVERAGE VOLUME

5-Day

5,042

10-Day

4,289

30-Day

6,101

1,193

Prev. Close

327.70
Open Price

319.30

Bid Price (Qty.)
320.00 (12)
Offer Price (Qty.)
320.25 (15)

NSE Live

Mar 04, 10:52

319.65 -6.75 (-2.07%)

Volume

AVERAGE VOLUME

5-Day

63,852

10-Day

67,057

30-Day

116,478

25,058

Prev. Close

326.40
Open Price

332.00

Bid Price (Qty.)
319.65 (110)
Offer Price (Qty.)
319.95 (31)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Panacea Biotec (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	-17.39	-18.31	-38.25	-32.84	22.98
Diluted EPS (Rs.)	-17.39	-18.31	-38.25	-32.84	22.98
Cash EPS (Rs.)	-5.75	-6.78	-24.19	-20.23	33.77
Book Value [ExclRevalReserve]/Share (Rs.)	74.77	84.54	103.27	143.50	106.89
Book Value [InclRevalReserve]/Share (Rs.)	74.77	84.54	103.27	143.50	106.89
Revenue from Operations/Share (Rs.)	112.10	84.07	99.26	115.84	190.52
PBDIT/Share (Rs.)	11.80	-10.87	-13.15	-12.64	46.41
PBIT/Share (Rs.)	0.84	-22.47	-27.18	-25.22	34.26
PBT/Share (Rs.)	-16.22	-18.10	-41.28	-41.65	25.18
Net Profit/Share (Rs.)	-16.72	-18.38	-38.22	-32.81	21.61
NP After MI And SOA / Share (Rs.)	-17.38	-18.29	-38.22	-33.55	23.60
Profitability Ratios
PBDIT Margin (%)	10.52	-12.93	-13.24	-10.91	24.36
PBIT Margin (%)	0.74	-26.72	-27.38	-21.77	17.98
PBT Margin (%)	-14.46	-21.53	-41.58	-35.95	13.21
Net Profit Margin (%)	-14.91	-21.85	-38.50	-28.32	11.34
NP After MI And SOA Margin (%)	-15.49	-21.75	-38.50	-28.96	12.38
Return on Networth/Equity (%)	-23.41	-21.86	-37.44	-23.55	22.29
Return on Capital Employed (%)	0.41	-12.44	-12.53	-10.80	18.13
Return on Assets (%)	-5.51	-5.76	-12.73	-10.54	8.34
Total Debt/Equity (X)	2.24	1.76	1.54	0.87	1.21
Asset Turnover Ratio (%)	35.59	26.51	33.07	36.41	67.35
Liquidity Ratios
Current Ratio (X)	0.74	0.46	0.85	1.01	1.41
Quick Ratio (X)	0.31	0.19	0.33	0.27	0.70
Inventory Turnover Ratio (X)	2.22	2.34	2.27	1.84	2.84
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	3.17
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	2.09
Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	96.83
Cash Earnings Retention Ratio (%)	0.00	0.00	0.00	0.00	97.91
Coverage Ratios
Interest Coverage Ratios (%)	0.05	-0.92	-1.61	-1.54	3.78
Interest Coverage Ratios (Post Tax) (%)	0.05	-0.92	-1.61	-1.54	3.78
Valuation Ratios
Enterprise Value (Cr.)	1,844.94	1,466.28	1,697.36	1,253.97	1,860.78
EV/Net Operating Revenue (X)	2.68	2.85	2.79	1.77	1.59
EV/EBITDA (X)	25.50	-22.00	-21.05	-16.18	6.54
MarketCap/Net Operating Revenue (X)	1.25	1.13	1.26	0.71	0.96
Retention Ratios (%)	0.00	0.00	0.00	0.00	96.82
Price/BV (X)	1.89	1.13	1.22	0.57	1.72
Price/Net Operating Revenue	1.25	1.13	1.26	0.71	0.96
Earnings Yield	-0.12	-0.19	-0.31	-0.41	0.13